Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 303-310
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.303
Table 1 Patient sex at birth for gout with and without a history of cirrhosis
Patients without cirrhosis, n = 1491829
Patients with cirrhosis, n = 36948
OR
95%CI
P value
Percentage
n
Percentage
n
Sex at birthFemale33.1749489025.3793720.6850.669-0.701< 0.05
Male66.8399693974.6327576
Table 2 Differences in age distribution among patients hospitalized for gout with and without a history of cirrhosis

Patients without cirrhosis
Patients with cirrhosis
Mean difference
95%CI
P value
Mean
SD
SE mean
Mean
SD
SE mean
Age at admission (yr)70.3713.530.01166.2112.330.0644.167 ± 0.0714.027-4.306< 0.05
Table 3 Racial characteristics in patients hospitalized for gout with and without a history of cirrhosis
Race
Patients without cirrhosis
Patients with cirrhosis
P value
%
n
%
n
Caucasian71.089004069.122725< 0.05
Black18.623300517.45723
Hispanic4.4551747.42426
Asian or Pacific Islander3.6452173.61184
Native American0.342890.4122
Other2.0253512.1703
Table 4 Primary outcomes in gout among hospitalized patients with and without cirrhosis

Patients without cirrhosis
Patients with cirrhosis
OR
95%CI
P value
AOR
ACI
Adjusted P value
Percentage
n
Percentage
n
Mortality2.03302865.4920292.8042.678-2.937< 0.0503.0922.939-3.252< 0.05
Gout flare2.77412822.8910661.0440.982-1.1100. 1710.8160.765-0.871< 0.05
Tophi0.75112020.973581.2931.164-1.438< 0.0501.0250.914-1.1490.677
Uric acid nephrolithiasis0.023740.0290.9720.502-1.8820.9321.0370.530-2.0300.915
Nephropathy0.022830.0150.7130.295-1.7270.4520.5480.223-1.3460.19
Arthrocentesis2.45366112.218180.9000.839-0.965< 0.0500.7410.686-0.800< 0.05
Joint injection0.72106730.521920.7250.628-0.837< 0.0500.7130.610-0.833< 0.050
Septic Arthritis0.3146370.311140.9930.824-1.1960.9390.9970.821-1.2110.977